Kang et al. have shown that down regulation of CD276 can significantly reduce cell migration and invasion in HCC, which may be referred to epithelial-to-mesenchymal transition through the JAK2/STAT3/Slug pathway 16. Here, CD276 is linked to hepatocellular carcinoma.